United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services

SILVER SPRING, Md., April 29, 2019 -- (Healthcare Sales & Marketing Network) -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that its collaborator, XVIVO Perfusion, Inc., a subsidiary of XVIVO Perfusion AB (STO: XVIVO), has received Prem... Devices, FDA United Therapeutics, XVIVO Perfusion, STEEN Solution
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news